The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation

Neuroscience

Volumn 259, Issue , 2014, Pages 43-52

  Yamamoto, T ^a   Uchiyama, T ^a   Sakakibara, R ^b   Taniguchi, J ^a   Kuwabara, S ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

Deep brain stimulation; Local field potential; Parkinson's disease; Striatal monoamine; Subthalamic nucleus

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; MONOAMINE; SEROTONIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA RHYTHM; BRAIN DEPTH STIMULATION; BRAIN ELECTROPHYSIOLOGY; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; ELECTRIC POTENTIAL; EXTRACELLULAR FLUID; FEMALE; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBTHALAMIC NUCLEUS;

3-4-DIHYDROXYPHENYLACETIC ACID; 5-HIAA; 5-HYDROXYINDOLEACETIC ACID; 6-HYDROXYDOPAMINE; 6-OHDA; DA; DEEP BRAIN STIMULATION; DOPAC; DOPAMINE; EDTA; ETHYLENEDIAMINETETRAACETIC ACID; FAST FOURIER TRANSFORM; FFT; H(2)O(2); HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOVANILLIC ACID; HPLC; HVA; HYDROGEN PEROXIDE; LFP; LOCAL FIELD POTENTIAL; PARKINSON'S DISEASE; PBS; PBS CONTAINING 0.05% TWEEN-20; PBST; PD; PHOSPHATE-BUFFERED SALINE; POWER SPECTRAL DENSITY; PSD; SNC; STN-DBS; STRIATAL MONOAMINE; SUBSTANTIA NIGRA PARS COMPACTA; SUBTHALAMIC NUCLEUS; SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION;

3,4-DIHYDROXYPHENYLACETIC ACID; ACTION POTENTIALS; ANIMALS; BIOGENIC MONOAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; ELECTRIC STIMULATION; FEMALE; HOMOVANILLIC ACID; MOTOR ACTIVITY; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SPECTRUM ANALYSIS; SUBTHALAMIC NUCLEUS;

EID: 84891100668     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.11.034     Document Type: Article

References (28)

1. Barraud Q., Obeid I., Aubert I., Barrière G., Contamin H., McGuire S., Ravenscroft P., Porras G., Tison F., Bezard E., Ghorayeb I. Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate. PLoS One 2010, 5:e13306. http://dx.doi.org/10.1016/j.expneurol.2011.08.027.
2. Benabid A.L., Chabardes S., Mitrofanis J., Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009, 8:67-81.
3. Bové J., Perier C. Neurotoxin-based models of Parkinson's disease. Neuroscience 2012, 211:51-76.
4. Brown P. Abnormal oscillatory synchronisation in the motor system leads to impaired movement. Curr Opin Neurobiol 2007, 17:656-664.
5. Bruet N., Windels F., Bertrand A., Feuerstein C., Poupard A., Savasta M. High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats. J Neuropathol Exp Neurol 2001, 60:15-24.
6. Cooper Jack R., Bloom Floyd E., Roth Robert H. The biochemical basis of neuropharmacology 2003, Oxford University Press, New York, p. 235. eighth ed.
7. Eusebio A., Thevathasan W., DoyleGaynor L., Pogosyan A., Bye E., Foltynie T., Zrinzo L., Ashkan K., Aziz T., Brown P. Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients. J Neurol Neurosurg Psychiatry 2011, 82:569-573.
8. Giannicola G., Marceglia S., Rossi L., Mrakic-Sposta S., Rampini P., Tamma F., Cogiamanian F., Barbieri S., Priori A. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease. Exp Neurol 2010, 226:120-127.
9. Gubellini P., Salin P., Kerkerian-Le Goff L., Baunez C. Deep brain stimulation in neurological diseases and experimental models: from molecule to complex behavior. Prog Neurobiol 2009, 89:79-123.
10. Hammond C., Bergman H., Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 2007, 30:357-364.
11. Hilker R., Voges J., Ghaemi M., Lehrke R., Rudolf J., Koulousakis A., Herholz K., Wienhard K., Sturm V., Heiss W.D. Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov Disord 2003, 18:41-48.
12. Humphries M.D., Gurney K. Network effects of subthalamic deep brain stimulation drive a unique mixture of responses in basal ganglia output. Eur J Neurosci 2012, 36:2240-2251.
13. Jenkinson N., Brown P. New insights into the relationship between dopamine, beta oscillations and motor function. Trends Neurosci 2011, 34:611-618.
14. Kringelbach M.L., Jenkinson N., Owen S.L., Aziz T.Z. Translational principles of deep brain stimulation. Nat Rev Neurosci 2007, 8:623-635.
15. Lacombe E., Carcenac C., Boulet S., Feuerstein C., Bertrand A., Poupard A., Savasta M. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats. Eur J Neurosci 2007, 26:1670-1680.
16. Marani E., Heida T., Lakke E.A.J.F., Usunoff K.G. The subthalamic nucleus. Part 1: development, cytology, topography and connections 2008, Springer-Verlag, Berlin, Heidelberg, pp. 75-89.
17. Meissner W., Reum T., Paul G., Harnack D., Sohr R., Morgenstern R., Kupsch A. Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats. Neurosci Lett 2001, 303:165-168.
18. Meissner W., Harnack D., Paul G., Reum T., Sohr R., Morgenstern R., Kupsch A. Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats. Neurosci Lett 2002, 328:105-108.
19. Navailles S., Benazzouz A., Bioulac B., Gross C., De Deurwaerdère P. High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease. J Neurosci 2010, 30:2356-2364.
20. Paul G., Reum T., Meissner W., Marburger A., Sohr R., Morgenstern R., Kupsch A. High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat. Neuroreport 2000, 28(11):441-444.
21. Pazo J.H., Höcht C., Barceló A.C., Fillipini B., Lomastro M.J. Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine. Synapse 2010, 64:905-915.
22. Perlmutter J.S., Mink J.W. Deep brain stimulation. Annu Rev Neurosci 2006, 29:229-257.
23. Ray N.J., Jenkinson N., Wang S., Holland P., Brittain J.S., Joint C., Stein J.F., Aziz T. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation. Exp Neurol 2008, 213:108-1013.
24. Tan S.K., Hartung H., Visser-Vandewalle V., Steinbusch H.W., Temel Y., Sharp T. A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission. Exp Neurol 2012, 233:145-153. 10.1016/j.expneurol.2011.08.027.
25. Walker R.H., Koch R.J., Moore C., Meshul C.K. Subthalamic nucleus stimulation and lesioning have distinct state-dependent effects upon striatal dopamine metabolism. Synapse 2009, 63:136-146.
26. Wallace L.J., Traeger J.S. Dopac distribution and regulation in striatal dopaminergic varicosities and extracellular space. Synapse 2012, 66:160-173.
27. Windels F., Bruet N., Poupard A., Feuerstein C., Bertrand A., Savasta M. Influence of the frequency parameter on extracellular glutamate and gamma-aminobutyric acid in substantia nigra and globus pallidus during electrical stimulation of subthalamic nucleus in rats. J Neurosci Res 2003, 72:259-267.
28. Windels F., Carcenac C., Poupard A., Savasta M. Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus. J Neurosci 2005, 18(25):5079-5086.